Energy Stocks Fall With Oil Prices — Energy Roundup
Energy stocks fell as oil prices continued to pull back from the 2024 highs set last week.
The front-month Nymex crude contract fell 1.4% to $85.23 a barrel.
The Energy Information Administration raised its estimate for average Brent crude oil prices this year to $89 a barrel from $87 previously, which it says "reflects our expectation of strong global oil inventory draws during this quarter and ongoing geopolitical risks." The Brent contract for June delivery settled at $89.42 a barrel on Tuesday.
U.S. crude oil inventories likely increased last week, while gasoline and distillates stocks are expected to have fallen, according to a survey by The Wall Street Journal.
Analysts forecast that ethanol inventories reported by the EIA on Wednesday may move closer to record highs set during the Covid-19 pandemic.
British energy giant BP expects higher oil and gas production to boost its first-quarter profit.
Write to Patrick Sullivan at patrick.sullivan@wsj.com
(END) Dow Jones Newswires
April 09, 2024 16:56 ET (20:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track